Sign in
4

Changes in Ownership

Axsome Therapeutics, Inc. Filed Acc 0001104659-17-040183

Options or other derivatives

  • Director acquired 30,197 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
POTTER MYRTLE S Director 2017-06-16 Grant or award · Stock Option (Right to Buy) +22,000 22,000 D
POTTER MYRTLE S Director 2017-06-16 Grant or award · Stock Option (Right to Buy) +8,197 8,197 D
Loading xslF345X03/a4.xml…